# Role of Hematological Parameters in the Stratification of COVID-19 Disease Severity

> **NCT04670328** · — · COMPLETED · sponsor: **FMH College of Medicine and Dentistry** · enrollment: 101 (actual)

## Conditions studied

- Covid19

## Interventions

- **DIAGNOSTIC_TEST:** not required

## Key facts

- **NCT ID:** NCT04670328
- **Lead sponsor:** FMH College of Medicine and Dentistry
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-05-01
- **Primary completion:** 2020-07-31
- **Final completion:** 2020-07-31
- **Target enrollment:** 101 (ACTUAL)
- **Last updated:** 2020-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04670328

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04670328, "Role of Hematological Parameters in the Stratification of COVID-19 Disease Severity". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04670328. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*